Association of iron overload based quantitative T2* MRI technique and carotid intima-media thickness in patients with beta-thalassemia: A cross-sectional study

BMC Cardiovascular Disorders

Volumn 10, Issue , 2010, Pages

  Akhlaghpoor, Shahram ^a   Hoseini, Morteza ^b   Jafarisepehr, Amirhosein ^b  

^a Noor Medical Imaging Center   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

DEFEROXAMINE; IRON;

ADULT; AGE; ARTERIAL WALL THICKNESS; ARTICLE; B SCAN; BETA THALASSEMIA; BLOOD TRANSFUSION; CAROTID ATHEROSCLEROSIS; CHILD; CONTROLLED STUDY; CORONARY RISK; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; IRON OVERLOAD; IRON STORAGE; LIVER LEVEL; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT COMPLIANCE; PRIORITY JOURNAL; SCHOOL CHILD; THALASSEMIA MAJOR; TREATMENT DURATION; ADOLESCENT; CAROTID ARTERY; ECHOGRAPHY; INTIMA; LIVER; METHODOLOGY; MIDDLE AGED; PATHOLOGY; TUNICA MEDIA;

ADOLESCENT; ADULT; BETA-THALASSEMIA; CAROTID ARTERIES; CHILD; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; IRON OVERLOAD; LIVER; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; TUNICA INTIMA; TUNICA MEDIA; YOUNG ADULT;

EID: 78650661481     PISSN: None     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/1471-2261-10-62     Document Type: Article

References (35)

1. Ruiz-Arguelles GJ, Lopez-Martinez B, Ruiz-Reyes G. Heterozygous beta-thalassemia: not infrequent in Mexico. Arch Med Res 2001, 32(4):293-295. 10.1016/S0188-4409(01)00284-3, 11440786.
2. Aldouri MA, Wonke B, Hoffbrand AV, Flynn DM, Laulicht M, Fenton LA, Scheuer PJ, Kibbler CC, Allwood CA, Brown D, et al. Iron state and hepatic disease in patients with thalassaemia major, treated with long term subcutaneous desferrioxamine. J Clin Pathol 1987, 40(11):1353-1359. 10.1136/jcp.40.11.1353, 1141239, 3121679.
3. Mavrogeni SI, Maris T, Gouliamos A, Vlahos L, Kremastinos DT. Myocardial iron deposition in beta-thalassemia studied by magnetic resonance imaging. Int J Card Imaging 1998, 14(2):117-122. 10.1023/A:1005922016048, 9617642.
4. Argyropoulou MI, Astrakas L. MRI evaluation of tissue iron burden in patients with beta-thalassaemia major. Pediatr Radiol 2007, 37(12):1191-1200. quiz 1308-1199, 10.1007/s00247-007-0567-1, 2292491, 17710390.
5. Christoforidis A, Haritandi A, Tsitouridis I, Tsatra I, Tsantali H, Karyda S, Dimitriadis AS, Athanassiou-Metaxa M. Correlative study of iron accumulation in liver, myocardium, and pituitary assessed with MRI in young thalassemic patients. J Pediatr Hematol Oncol 2006, 28(5):311-315. 10.1097/01.mph.0000212915.22265.3b, 16772883.
6. Papanikolaou G, Pantopoulos K. Iron metabolism and toxicity. Toxicol Appl Pharmacol 2005, 202(2):199-211. 10.1016/j.taap.2004.06.021, 15629195.
7. Qayyum R, Schulman P. Iron and atherosclerosis. Clin Cardiol 2005, 28(3):119-122.
8. Shah SV, Alam MG. Role of iron in atherosclerosis. Am J Kidney Dis 2003, 41(3 Suppl 1):S80-83. 10.1053/ajkd.2003.50091, 12612959.
9. Drueke T, Witko-Sarsat V, Massy Z, Descamps-Latscha B, Guerin AP, Marchais SJ, Gausson V, London GM. Iron therapy, advanced oxidation protein products, and carotid artery intima-media thickness in end-stage renal disease. Circulation 2002, 106(17):2212-2217. 10.1161/01.CIR.0000035250.66458.67, 12390950.
10. Gaenzer H, Marschang P, Sturm W, Neumayr G, Vogel W, Patsch J, Weiss G. Association between increased iron stores and impaired endothelial function in patients with hereditary hemochromatosis. J Am Coll Cardiol 2002, 40(12):2189-2194. 10.1016/S0735-1097(02)02611-6, 12505233.
11. Sullivan JL. Iron and the sex difference in heart disease risk. Lancet 1981, 1(8233):1293-1294. 10.1016/S0140-6736(81)92463-6, 6112609.
12. Ferrara DE, Taylor WR. Iron chelation and vascular function: in search of the mechanisms. Arterioscler Thromb Vasc Biol 2005, 25(11):2235-2237. 10.1161/01.ATV.0000189303.45609.1f, 16258147.
13. de Valk B, Marx JJ. Iron, atherosclerosis, and ischemic heart disease. Arch Intern Med 1999, 159(14):1542-1548. 10.1001/archinte.159.14.1542, 10421276.
14. Gillum RF. Body iron stores and atherosclerosis. Circulation 1997, 96(10):3261-3263.
15. Rossi E, McQuillan BM, Hung J, Thompson PL, Kuek C, Beilby JP. Serum ferritin and C282Y mutation of the hemochromatosis gene as predictors of asymptomatic carotid atherosclerosis in a community population. Stroke 2000, 31(12):3015-3020.
16. Haidari M, Javadi E, Sanati A, Hajilooi M, Ghanbili J. Association of increased ferritin with premature coronary stenosis in men. Clin Chem 2001, 47(9):1666-1672.
17. Manfroi WC, Zago AJ, Caramori PR, Cruz R, Oliveira J, Kirschnick LS, Ordovas K, Candiago RH, de Souza J, Ribeiro LW, et al. Does serum ferritin correlate with coronary angiography findings?. Int J Cardiol 1999, 69(2):149-153. 10.1016/S0167-5273(99)00020-0, 10549838.
18. Ooi GC, Khong PL, Chan GC, Chan KN, Chan KL, Lam W, Ng I, Ha SY. Magnetic resonance screening of iron status in transfusion-dependent beta-thalassaemia patients. Br J Haematol 2004, 124(3):385-390. 10.1046/j.1365-2141.2003.04772.x, 14717788.
19. Gandon Y, Olivie D, Guyader D, Aube C, Oberti F, Sebille V, Deugnier Y. Non-invasive assessment of hepatic iron stores by MRI. Lancet 2004, 363(9406):357-362. 10.1016/S0140-6736(04)15436-6, 15070565.
20. Rose C, Vandevenne P, Bourgeois E, Cambier N, Ernst O. Liver iron content assessment by routine and simple magnetic resonance imaging procedure in highly transfused patients. Eur J Haematol 2006, 77(2):145-149. 10.1111/j.0902-4441.2006.t01-1-EJH2571.x, 16608501.
21. Anderson LJ, Holden S, Davis B, Prescott E, Charrier CC, Bunce NH, Firmin DN, Wonke B, Porter J, Walker JM, et al. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 2001, 22(23):2171-2179. 10.1053/euhj.2001.2822, 11913479.
22. Meloni A, Ramazzotti A, Positano V, Salvatori C, Mangione M, Marcheschi P, Favilli B, De Marchi D, Prato S, Pepe A, et al. Evaluation of a web-based network for reproducible T2* MRI assessment of iron overload in thalassemia. Int J Med Inform 2009, 78(8):503-512. 10.1016/j.ijmedinf.2009.02.011, 19345609.
23. Di Tucci AA, Matta G, Deplano S, Gabbas A, Depau C, Derudas D, Caocci G, Agus A, Angelucci E. Myocardial iron overload assessment by T2* magnetic resonance imaging in adult transfusion dependent patients with acquired anemias. Haematologica 2008, 93(9):1385-1388. 10.3324/haematol.12759, 18603557.
24. McLeod C, Fleeman N, Kirkham J, Bagust A, Boland A, Chu P, Dickson R, Dundar Y, Greenhalgh J, Modell B, et al. Deferasirox for the treatment of iron overload associated with regular blood transfusions (transfusional haemosiderosis) in patients suffering with chronic anaemia: a systematic review and economic evaluation. Health Technol Assess 2009, 13(1):iii-iv. ix-xi, 1-121.
25. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 1999, 340(1):14-22.
26. Ascherio A, Rimm EB, Giovannucci E, Willett WC, Stampfer MJ. Blood donations and risk of coronary heart disease in men. Circulation 2001, 103(1):52-57.
27. Ramakrishna G, Rooke TW, Cooper LT. Iron and peripheral arterial disease: revisiting the iron hypothesis in a different light. Vasc Med 2003, 8(3):203-210. 10.1191/1358863x03vm493ra, 14989563.
28. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993, 362(6423):801-809. 10.1038/362801a0, 8479518.
29. Kablak-Ziembicka A, Przewlocki T, Tracz W, Pieniazek P, Musialek P, Sokolowski A. Gender differences in carotid intima-media thickness in patients with suspected coronary artery disease. Am J Cardiol 2005, 96(9):1217-1222. 10.1016/j.amjcard.2005.06.059, 16253585.
30. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989, 320(14):915-924. 10.1056/NEJM198904063201407, 2648148.
31. Steinberg D. Antioxidants and atherosclerosis. A current assessment. Circulation 1991, 84(3):1420-1425.
32. Steinbrecher UP, Zhang HF, Lougheed M. Role of oxidatively modified LDL in atherosclerosis. Free Radic Biol Med 1990, 9(2):155-168. 10.1016/0891-5849(90)90119-4, 2227530.
33. Halliwell B, Chirico S. Lipid peroxidation: its mechanism, measurement, and significance. Am J Clin Nutr 1993, 57(5 Suppl):715S-724S. discussion 724S-725S.
34. Chrysohoou C, Panagiotakos DB, Pitsavos C, Kosma K, Barbetseas J, Karagiorga M, Ladis I, Stefanadis C. Distribution of serum lipids and lipoproteins in patients with beta thalassaemia major; an epidemiological study in young adults from Greece. Lipids Health Dis 2004, 3:3. 10.1186/1476-511X-3-3, 385250, 15023232.
35. Cheung YF, Chow PC, Chan GC, Ha SY. Carotid intima-media thickness is increased and related to arterial stiffening in patients with beta-thalassaemia major. Br J Haematol 2006, 135(5):732-734. 10.1111/j.1365-2141.2006.06349.x, 17107355.